Johnson & Johnson (JNJ): FY25 Q2 earnings call, Jul 16, 2025
No Kalshi or Polymarket word markets were listed for Johnson & Johnson’s Jul 16, 2025 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
2 matches for “Administration”; 2 quoted, at least 25 words apart.
…the most favored nation concepts. With respect to MFN we share the administration's goal that American patients should pay less by addressing the real drivers…
…70% of their prescriptions within IBD, looking forward to getting the subcutaneous administration approval for lung cancer with RYBREVANT/LAZCLUZE. And then on the med tech…
Agents: this page as TSV at /api/v1/appearances/johnson-and-johnson:2025-07-16:earnings_call · words: /api/v1/brief?appearance=johnson-and-johnson:2025-07-16:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP